In addition to FDG, several other tracers like PSMA, Choline, DOTATATE, and Methionine are increasingly used in the management of diverse pathologies such as prostate cancer, central nervous system and neuroendocrine tumors (3, 16, 19). This evidence concerns the gene FOLH1 and neuroendocrine neoplasm.